Physical Medicine & Rehabilitation, Pain Medicine · Brooklyn, NY
NPI
1245265586
Since 2006
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3065 Brighton 14th St
Brooklyn, NY, 11235
Phone (718) 496-8755
Medicare paid, 2024
$234K
2,507 services
Medicare patients, 2024
546
Average age 79
Drug cost, 2024
$41K
310 prescriptions
Company payments, 2025
$630
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tatyana Kisina was code 95886 (electrical nerve conductivity), 799 times for 285 patients. In total Tatyana Kisina billed 2,507 services in 16 codes, and Medicare paid $234K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 799 | 285 | $75.28 | $60K |
| 99213 Office E&M - Established | Office | 519 | 295 | $70.22 | $36K |
| 99214 Office E&M - Established | Office | 449 | 258 | $96.16 | $43K |
| 95911 Electrical Nerve Conductivity | Office | 391 | 279 | $165.15 | $65K |
| 99204 Office E&M - New | Office | 103 | 103 | $126.35 | $13K |
| 99212 Office E&M - Established | Office | 97 | 90 | $43.85 | $4,254 |
| 99203 Office E&M - New | Office | 94 | 94 | $85.38 | $8,026 |
| 99202 Office E&M - New | Office | 26 | 26 | $52.69 | $1,370 |
By year: 2022 $192K for 1,732 services; 2023 $243K for 2,292 services; 2024 $234K for 2,507 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tatyana Kisina prescribed most often to Medicare patients was Doxepin Hcl, with 100 prescriptions and refills. In total Tatyana Kisina wrote 310 Medicare prescriptions that cost $41K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxepin Hcl Generic | 100 | 100 | 58 | $26K |
| Lidocaine Hcl Viscous Lidocaine Hcl | 85 | 85 | 49 | $5,298 |
| Celecoxib Generic | 72 | 72 | 47 | $5,116 |
| Diclofenac Potassium Generic | 39 | 39 | 30 | $3,497 |
Brand drugs: 0 claims; generic drugs: 310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tatyana Kisina $630 ($630 in general payments such as food, travel and fees) from 9 companies. The largest payer was Sumitomo Pharma America, Inc. with $269.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 17 | $269 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $76.43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $67.93 |
| Amgen Inc. AMGN | 3 | $57.17 |
| Lilly USA, LLC LLY | 2 | $47.86 |
| Abbvie Inc. ABBV | 2 | $40.77 |
| Axsome Therapeutics, Inc. AXSM | 1 | $29.17 |
| GlaxoSmithKline, LLC. GSK | 1 | $23.75 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.